<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-15T10:16:52Z</responseDate>
  <request identifier="oai:figshare.com:article/20044757" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/20044757</identifier>
        <datestamp>2022-06-11T04:27:31Z</datestamp>
        <setSpec>category_26209</setSpec>
        <setSpec>portal_959</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_06_2022</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation</dc:title>
          <dc:creator>Kristie Stefanoska (12840116)</dc:creator>
          <dc:creator>Arne Ittner (337884)</dc:creator>
          <dc:creator>Mehul Gajwani (12840119)</dc:creator>
          <dc:creator>Amanda RP Tan (12840122)</dc:creator>
          <dc:creator>Holly Ahel (12840125)</dc:creator>
          <dc:creator>Prita Asih (7487609)</dc:creator>
          <dc:creator>Alexander Volkerling (3220491)</dc:creator>
          <dc:creator>Anne Poljak (158842)</dc:creator>
          <dc:subject>Other education not elsewhere classified</dc:subject>
          <dc:subject>Medical and health sciences</dc:subject>
          <dc:description>Hyper-phosphorylation of the neuronal tau protein is a hallmark of neurodegenerative tauopathies like Alzheimer’s disease. A central unanswered question is why tau becomes progressively hyper-phosphorylated. Here, we show that tau phosphorylation is governed by interdependence - a mechanistic link between initial site-specific and subsequent multi-site phosphorylation. Systematic assessment of site interdependence identified distinct residues (Threonine-50, -69, -181) as master sites that determine propagation of phosphorylation at multiple epitopes. CRISPR point mutation and expression of human tau in Alzheimer’s mice showed that site interdependence governs physiologic and amyloid-associated multi-site phosphorylation and cognitive deficits, respectively. Combined targeting of master sites and p38α, the most central tau kinase linked to interdependence, synergistically ablated hyper-phosphorylation. In summary, our work delineates how complex tau phosphorylation arises to inform therapeutic and biomarker design for tauopathies.

&lt;h3&gt;Methods&lt;/h3&gt;
Raw Immunoblot data for Figure 1. Chemiluninescence signals were imaged on a ChemiDoc MP (Biorad) digital system.</dc:description>
          <dc:date>2022-05-13T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.5061/dryad.bvq83bkc0</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Alzheimer_s_disease_Ablating_single_master_site_abolishes_tau_hyperphosphorylation/20044757</dc:relation>
          <dc:rights>CC0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
